Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )-细胞/细菌培养-试剂-生物在线
翌圣生物科技(上海)股份有限公司
Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )

Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )

商家询价

产品名称: Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )

英文名称: Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )

产品编号: 92274ES60

产品价格: 0

产品产地: Yeasen

品牌商标: Yeasen

更新时间: 2024-12-10T13:22:33

使用范围: null

翌圣生物科技(上海)股份有限公司
  • 联系人 : 李自转
  • 地址 : 上海市浦东新区天雄路166弄一号楼三层南单元
  • 邮编 : 200030
  • 所在区域 : 上海
  • 电话 : 139****5640 点击查看
  • 传真 : 点击查看
  • 邮箱 : lizizhuan@yeasen.com
  • 二维码 : 点击查看

 Product Information

 

Product Name

Cat#

Size

Price(¥

Recombinant Human R-Spondin-1 Protein,His (Human RSPO1,His )

92274ES60

100 μg

5775.00

92274ES80

1 mg

31425.00

 

Product Description

 

R-Spondin 1 (RSPO1, Roof plate-specific Spondin 1), also known as cysteine-rich and single thrombospondin domain containing protein 3, is a 27 kDa secreted protein that shares ~40% aa identity with three other R-Spondin family members . All R-Spondins regulate Wnt/ beta-Catenin signaling but have distinct expression patterns. In humans, rare disruptions of the R-Spondin 1 gene are associated with tendencies for XX sex reversal (phenotypic male) or hermaphroditism, indicating a role for R-Spondin 1 in gender- Injection of recombinant R-Spondin 1 in mice causes activation of beta-catenin and proliferation of intestinal crypt epithelial cells, and ameliorates experimental colitis. Interest in R-Spondin 1 as a cell culture supplement has grown with the expansion of the organoid field. R-Spondin 1 is widely used in organoid cell culture workflows as a vital component that promotes both growth and survival of 3D organoids .

 

Product Properties

 

Synonyms

R-Spondin 1 ;Roof Plate-specific Spondin 1

Accession

Q2MKA7

Source

HEK293 Cells-derived human RSPO1 protein, Met1 22-Ala 263 with His tag at the C-terminus.

Molecular Weight

Approximately 28.2 kDa. As a result of glycosylation, RSPO1 migrates as an approximately 42 kDa band in SDS-PAGE under reducing conditions.

AA Sequence

MRLGLCVVAL VLSWTHLTIS SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA    

Tag

His

Physical Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

Purity

> 95% by SDS-PAGE.

Biological Activity

1. Measured by its ability to induce activation of ß-catenin response in a Topflash Luciferase assay using HEK293T human embryonic kidney cells. The ED50 for this effect is typically 0.1-0.9 μg/mL in the presence of 5 ng/mL recombinant mouse Wnt3a.

2. Measured by its binding ability in a functional ELISA. Immobilized human RSPO1 at 20 μg/ml (100 μl/well) can bind human LIMPII with a linear range of 32-800 ng/ml.
3. Measured by its binding ability in a functional ELISA. Immobilized human RSPO1 at 20 μg/ml (100 μl/well) can bind mouse CD36 with a linear range of 6.4-800 ng/ml.

Endotoxin

< 1.0 EU per 1μg of the protein by the LAL method.

Formulation

Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.


Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.

 

Shipping and Storage

 

The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

Cautions

 

1. Avoid repeated freeze-thaw cycles.

2. For your safety and health, please wear lab coats and disposable gloves for operation.

3. For research use only.

 

 

 

HB220413